Supply Issues B Braun Medical Ltd Introcan Safety 3 IV Cannula 22G FSP2619 (ICN 3225)

• The supply issue with Introcan Safety 3 IV Cannula products from B Braun Medical Ltd is now resolved.
• FSP2619 is now available to order through our online catalogue.
• This ICN is now closed.

• The supply issue with Introcan Safety 3 IV Cannula products from B Braun Medical Ltd is continuing.
• One product remains subject to Protect Demand Management:
  • FSP2619 – Safety Peripheral Intravenous Cannula Non-Ported with Wings Blue 22G x 25mm PUR with blood control technology.
• One product remains affected in total.
• FSP2619 is available to order through NHS Supply Chain. However, trusts are allocated a maximum daily quantity or “threshold” to ensure fair supply of available stock across the NHS.
• See our Downloads ▼ section to access the product listing for further information on the affected product code and potential alternatives and for a full list of product codes subject to Protect Demand Management.
• We will continue to review the stock to minimise further disruption and will update this ICN as soon as we have further information.
• The supply issue is now anticipated to be resolved by 26 February 2026.

Change:

• The supplier B. Braun Medical Ltd has informed us of a supply issue with its Introcan Safety 3 IV Cannula products.
• There is one product affected:
  • FSP2619 – Safety Peripheral Intravenous Cannula Non-Ported with Wings Blue 22G x 25mm PUR with blood control technology
• Product shipments are currently delayed because of a supplier IT issue.
• Due to this ongoing supply issue this product is now being threshold managed as it is subject to Protect Demand Management.

Impact:

• FSP2619 is available to order through NHS Supply Chain. However, trusts are allocated a maximum daily quantity or “threshold” to ensure fair supply of available stock across the NHS.
• Potential indirect alternative products are available to order through our online catalogue.
• See our Downloads ▼ section to access the product listing for further information on the affected product code and potential alternatives.
• The supply issue is anticipated to be resolved by 2 February 2026.

Next Steps:              

• Customers are advised to log into our website to view the potential indirect alternative products.
• The continuing supply issue is being monitored in conjunction with the supplier, and we will continue to review the stock situation to minimise further disruption and update this ICN with the latest information as it becomes available.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.

Please note that due to the clinical nature of these alternative products, we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.